SCHEMBL5530299

SCHEMBL5530299

Cc1ccc(-c2nc(NCCCC(=O)O)c3ccccc3n2)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT5 Q9NXA8 1/20 0.70
RAD52 P43351 2/20 0.69
PDE5A O76074 3/20 0.69
POLB P06746 2/20 0.65
SMARCA2 P51531 1/20 0.65
ACP1 P24666 1/20 0.62
HMOX1 P09601 1/20 0.59
MEN1 O00255 3/20 0.59
KMT2A Q03164 3/20 0.59
KDM4E B2RXH2 2/20 0.58
RECQL P46063 2/20 0.58
ALOX15 P16050 2/20 0.57
HSD17B10 Q99714 2/20 0.57
USP2 O75604 1/20 0.57
MAPT P10636 3/20 0.57
MAPK1 P28482 2/20 0.57
TP53 P04637 2/20 0.57
ALDH1A1 P00352 2/20 0.57
LATS1 O95835 1/20 0.56
LMNA P02545 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8270077 0.84 CYP1A2 (0.62) SIRT5RAD52PDE5APOLBACP1
SCHEMBL8270970 0.83 RAD52 (0.49) SIRT5RAD52PDE5APOLBSMARCA2
SCHEMBL13381601 0.82 PDE5A (0.57) SIRT5PDE5AACP1MEN1KMT2A
SCHEMBL8268379 0.82 PDE5A (0.64) SIRT5PDE5AACP1MEN1KMT2A
SCHEMBL1083831 0.82 MEN1 (0.80) RAD52PDE5APOLBSMARCA2ACP1
SCHEMBL1085482 0.81 PDE5A (1.00) SIRT5PDE5APOLBACP1MEN1
SCHEMBL8268384 0.80 SIRT5 (0.61) SIRT5PDE5APOLBACP1MEN1
SCHEMBL8269549 0.79 PDE5A (0.86) SIRT5RAD52PDE5APOLBACP1
SCHEMBL14758542 0.79 RAD52 (1.00) RAD52PDE5APOLBSMARCA2ACP1
SCHEMBL1084107 0.78 SMN1; SMN2 (0.81) RAD52PDE5APOLBSMARCA2HMOX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070197509-A1 Compositions and methods for modulating gated ion channels PAINCEPTOR PHARMA CORPORATION (CA) 2007-08-23 US disclosed
US-20070197509-A1 Compositions and methods for modulating gated ion channels PAINCEPTOR PHARMA CORPORATION (CA) 2007-08-23 US disclosed
US-20070197509-A1 Compositions and methods for modulating gated ion channels PAINCEPTOR PHARMA CORPORATION (CA) 2007-08-23 US disclosed
WO-2007071055-A1 COMPOSITIONS AND METHODS FOR MODULATING GATED ION CHANNELS PAINCEPTOR PHARMA CORPORATION (CA) 2007-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197509-A1 Compositions and methods for modulating gated ion channels KCNN3, KCNN2, HCN3 SIRT5 2352/4885RAD52 4694/4885PDE5A 850/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.